Salt and Pro-Drug Forms

The same active drug molecule can be delivered in different chemical forms. A salt pairs an ionisable drug with a counterion to alter its solubility, stability, and handling without changing the active species, while a prodrug is an inactive or less-active precursor that is converted to the active drug in the body. Both are strategies for optimising how a fixed pharmacophore is formulated and absorbed.

Definition

A salt form is a drug substance in which an acidic or basic drug is combined with a counterion to form an ionic solid, modifying physicochemical properties without altering the active moiety; a prodrug is a chemically modified, typically inactive derivative of a drug that is converted to the active compound in the body by enzymatic or chemical processes.

Scope

This topic covers the form-based classification of drugs: pharmaceutical salts and their counterions, and prodrugs and their bioactivation. It explains why these forms are used, how they relate to the parent active molecule, and the principles behind salt selection and prodrug design. It is an educational overview and does not give guidance on dosing, formulation choice for individuals, or clinical use.

Core questions

• Why is an active drug often marketed as a salt rather than the free acid or base?
• How does counterion choice influence solubility, stability, and processability?
• What is a prodrug and why is bioactivation used?
• How do salt and prodrug forms relate to the same underlying active molecule?

Key concepts

• Pharmaceutical salt
• Counterion selection
• Free acid / free base
• Solubility and dissolution
• Prodrug
• Bioactivation
• Promoiety
• Improved absorption and targeting

Mechanisms

Salt formation exploits the ionisable functional groups of a drug: pairing an acidic or basic molecule with a suitable counterion yields a crystalline salt that can have improved aqueous solubility, dissolution rate, stability, or manufacturability while releasing the identical active moiety in solution. Salt selection therefore balances physicochemical and pharmaceutical properties against the availability of acceptable counterions, as catalogued in pharmaceutical-salt reference works. Prodrugs take a different approach: a temporary chemical group (a promoiety) is attached to mask or modify the active molecule, producing a precursor that is absorbed or distributed more favourably and then cleaved — enzymatically or chemically — to liberate the active drug at or after absorption. Rautio and colleagues describe how prodrug design is used to overcome barriers such as poor permeability, low solubility, rapid metabolism, or lack of site selectivity.

Clinical relevance

Salt and prodrug forms explain why the name on a product may differ from the active moiety and why two formulations of the same drug can behave differently in absorption or stability. This entry describes these chemical strategies as a classification of drug forms; it is background information and not advice on selecting a formulation, dose, or route for any patient.

Evidence & guidelines

Salt selection and prodrug design are documented in dedicated reference works — notably the IUPAC-associated handbook of pharmaceutical salts — and in influential reviews of prodrug strategy. Pharmacopoeial monographs define accepted salt forms, though those standards lie outside the descriptive scope of this entry.

History

Using salts to render acidic or basic drugs into stable, soluble solids is long-standing pharmaceutical practice, later systematised through formal salt-selection guidance and the collaborative pharmaceutical-salt handbook. The prodrug concept, articulated and named in the mid-twentieth century, matured into a deliberate design discipline as chemists used temporary modifications to solve absorption, stability, and targeting problems, with reviews consolidating the strategy in the modern era.

Debates

How should a salt form be selected for a new drug?

Salt selection trades off solubility, stability, crystallinity, and counterion acceptability, and because no single property dominates, choosing among candidate salts remains a multi-criteria judgement guided by experiment rather than a fixed rule.

Key figures

• Jarkko Rautio
• P. Heinrich Stahl
• Camille Wermuth

Seminal works

• rautio-2008
• stahl-wermuth-2011

Frequently asked questions

Why is a drug often sold as a salt?

Forming a salt by pairing an ionisable drug with a counterion can improve its solubility, dissolution, stability, or manufacturability while releasing exactly the same active molecule in the body.

What is a prodrug?

A prodrug is an inactive or less-active chemical precursor of a drug that is converted to the active compound in the body, a strategy used to improve absorption, stability, or targeting of the active molecule.